ATE493497T1 - Verfahren zur herstellung von oligopeptiden - Google Patents

Verfahren zur herstellung von oligopeptiden

Info

Publication number
ATE493497T1
ATE493497T1 AT07733646T AT07733646T ATE493497T1 AT E493497 T1 ATE493497 T1 AT E493497T1 AT 07733646 T AT07733646 T AT 07733646T AT 07733646 T AT07733646 T AT 07733646T AT E493497 T1 ATE493497 T1 AT E493497T1
Authority
AT
Austria
Prior art keywords
oligopeptides
nucleic acid
acid sequence
fusion protein
synthesizing
Prior art date
Application number
AT07733646T
Other languages
English (en)
Inventor
Shisong Jiang
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE493497T1 publication Critical patent/ATE493497T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT07733646T 2006-04-28 2007-04-30 Verfahren zur herstellung von oligopeptiden ATE493497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0608368.7A GB0608368D0 (en) 2006-04-28 2006-04-28 Process for making Oligopeptides
PCT/GB2007/050225 WO2007125371A2 (en) 2006-04-28 2007-04-30 Process for making oligopeptides

Publications (1)

Publication Number Publication Date
ATE493497T1 true ATE493497T1 (de) 2011-01-15

Family

ID=36589936

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07733646T ATE493497T1 (de) 2006-04-28 2007-04-30 Verfahren zur herstellung von oligopeptiden

Country Status (7)

Country Link
US (1) US9382546B2 (de)
EP (1) EP2041286B1 (de)
CN (1) CN101512000B (de)
AT (1) ATE493497T1 (de)
DE (1) DE602007011616D1 (de)
GB (1) GB0608368D0 (de)
WO (1) WO2007125371A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090024292A (ko) * 2006-06-28 2009-03-06 스태튼스 세룸 인스티튜트 단백질 단편 또는 펩타이드 혼합물로서 전달되는 항원을 가진 백신접종에 의해 준우성 항원결정기를 포함하는 ｔ세포 레퍼토리 확장
EP2620446A1 (de) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogene zur HIV-Impfung
CN105753989A (zh) * 2014-12-15 2016-07-13 牛津疫苗医学生物科技（英国）有限公司 人工多抗原融合蛋白及其制备和应用
CN113924114A (zh) 2019-05-22 2022-01-11 吉利德科学公司 Tlr7调节化合物和hiv疫苗的组合
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines
GB202017119D0 (en) 2020-10-28 2020-12-09 Oxford Vacmedix Uk Ltd Polypeptides for cancer treatment
GB202017118D0 (en) 2020-10-28 2020-12-09 Oxford Vacmedix Uk Ltd Coronavirus polypeptide
GB202019767D0 (en) 2020-12-15 2021-01-27 Chain Biotechnology Ltd Compostitions and methods
EP4337322A1 (de) 2021-05-11 2024-03-20 Oxford Vacmedix UK Ltd. Impfstoffformulierung mit rekombinanten überlappenden peptiden und nativen proteinen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795974A (en) * 1993-12-10 1998-08-18 University Of Utah Research Foundation Mycoplasma arthritidis superantigen
CZ321497A3 (cs) 1995-04-11 1998-06-17 Merck And Co., Inc. Způsob vhodný pro produkci látek, jejichž základ tvoří dipeptid
SE9903031D0 (sv) * 1999-08-27 1999-08-27 Eurodiagnostica Ab Peptide mixture and vaccine against a chronic viral infection
CN1255548C (zh) * 2001-06-15 2006-05-10 霍夫曼-拉罗奇有限公司 gp41片段的乙酰化
WO2004002415A2 (en) * 2002-06-27 2004-01-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating a cytotoxic t lymphocyte immune response

Also Published As

Publication number Publication date
GB0608368D0 (en) 2006-06-07
DE602007011616D1 (de) 2011-02-10
US20100291061A1 (en) 2010-11-18
WO2007125371A3 (en) 2008-03-13
WO2007125371A2 (en) 2007-11-08
CN101512000A (zh) 2009-08-19
EP2041286B1 (de) 2010-12-29
US9382546B2 (en) 2016-07-05
CN101512000B (zh) 2016-08-03
EP2041286A2 (de) 2009-04-01

Similar Documents

Publication Publication Date Title
DE602007011616D1 (de) Verfahren zur herstellung von oligopeptiden
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
MX358725B (es) Antigenos prostaticos de consenso, molecula de acido nucleico que los codifica y vacuna y usos que los comprenden.
PE20110310A1 (es) Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas
EP2865387A3 (de) Priming einer Immunantwort
DE60311731D1 (de) Verfahren zur rekombinanten Herstellung von Antifusogenikpeptide
MX2019004648A (es) Peptidos escindibles y proteinas insecticidas y nematicidas que los comprenden.
CY1113153T1 (el) ΙL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
EP2395091A3 (de) Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu deren Herstellung
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
EP2468881A3 (de) Mehrfache Genexpression mit sORF-Konstrukten und Verfahren mit Polyproteinen, Pro-Proteinen und Proteolyse
JP2007516696A5 (de)
WO2009007244A3 (en) Replication deficient influenza virus for the expression of heterologous sequences
ZA200803486B (en) Expression of proteins in plants
ES2531372T3 (es) Enzimas de procesamiento fusionadas a marcadores de proteínas básicas
WO2006090385A3 (en) Protease inhibitors and method of screening thereof
WO2010132341A3 (en) Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
ES2531115T3 (es) Combinaciones de clados de RrgB neumocócicos
PE20090683A1 (es) Peptidos de senalizacion
NZ596501A (en) Casb7439 constructs
ATE533851T1 (de) Prozess zur herstellung eines plastidgerichteten proteins in pflanzenzellen
TW201008576A (en) New fusion proteins and their use for the preparation of vaccines against hepatitis C
ATE469655T1 (de) Bakteriophagenvermittelte impfung
ATE374825T1 (de) Verwendung von caspasen zur herstellung von reifen rekombinanten fusionsproteinen
DE602005017034D1 (de) Signalpeptid zur herstellung eines polypeptids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties